Kato Kambartel

698 total citations
6 papers, 184 citations indexed

About

Kato Kambartel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kato Kambartel has authored 6 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Kato Kambartel's work include Lung Cancer Treatments and Mutations (4 papers), Metastasis and carcinoma case studies (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Kato Kambartel is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Metastasis and carcinoma case studies (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Kato Kambartel collaborates with scholars based in Germany, United States and United Kingdom. Kato Kambartel's co-authors include M Bennetts, Michael Moran, Antonin Kayser, Maik Häntschel, Dana J. Nickens, Federico Cappuzzo, Barbara Melosky, Julia Brinkmann, Christian Roesel and Thomas Voshaar and has published in prestigious journals such as Journal of Clinical Oncology, European Respiratory Journal and Journal of Thoracic Oncology.

In The Last Decade

Kato Kambartel

5 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kato Kambartel Germany	4	150	104	59	41	12	6	184
Ernesto Korbenfeld Argentina	8	133 0.9×	113 1.1×	44 0.7×	50 1.2×	11 0.9×	28	182
Sucheta More India	6	99 0.7×	69 0.7×	17 0.3×	34 0.8×	7 0.6×	24	141
Kylie Prutisto-Chang United States	2	119 0.8×	85 0.8×	62 1.1×	47 1.1×	9 0.8×	3	162
Chinyere E. Okpara United States	7	100 0.7×	100 1.0×	34 0.6×	35 0.9×	21 1.8×	26	163
Delan Li China	7	118 0.8×	134 1.3×	69 1.2×	39 1.0×	12 1.0×	13	195
Jude Ngang Australia	4	89 0.6×	108 1.0×	106 1.8×	43 1.0×	4 0.3×	5	193
Despina Thomaidou United States	8	214 1.4×	142 1.4×	123 2.1×	60 1.5×	21 1.8×	23	276
Patricia Maeda United States	7	54 0.4×	82 0.8×	45 0.8×	28 0.7×	18 1.5×	16	168
Mohammad Atiq United States	6	64 0.4×	88 0.8×	54 0.9×	26 0.6×	7 0.6×	21	155
Brian DiCarlo United States	7	92 0.6×	105 1.0×	45 0.8×	23 0.6×	24 2.0×	11	162

Countries citing papers authored by Kato Kambartel

Since Specialization

Citations

This map shows the geographic impact of Kato Kambartel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kato Kambartel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kato Kambartel more than expected).

Fields of papers citing papers by Kato Kambartel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kato Kambartel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kato Kambartel. The network helps show where Kato Kambartel may publish in the future.

Co-authorship network of co-authors of Kato Kambartel

This figure shows the co-authorship network connecting the top 25 collaborators of Kato Kambartel. A scholar is included among the top collaborators of Kato Kambartel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kato Kambartel. Kato Kambartel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Melosky, Barbara, Kato Kambartel, Maik Häntschel, et al.. (2021). Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis. Molecular Diagnosis & Therapy. 26(1). 7–18. 124 indexed citations

2.

Melosky, B., Eckart Laack, Kato Kambartel, et al.. (2021). P37.17 Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis. Journal of Thoracic Oncology. 16(3). S449–S449. 1 indexed citations

3.

Metzenmacher, Martin, Kato Kambartel, Jens Panse, et al.. (2021). Real-World Efficacy of Docetaxel Plus Nintedanib After Chemo-Immunotherapy Failure in Advanced Pulmonary Adenocarcinoma. Future Oncology. 17(30). 3965–3976. 7 indexed citations

4.

Roesel, Christian, et al.. (2019). Lazarus-Type Tumour Response to Therapy with Nivolumab for Sarcomatoid Carcinomas of the Lung. Current Oncology. 26(2). 270–273. 16 indexed citations

5.

Nogová, Lucia, Lecia V. Sequist, Philippe A. Cassier, et al.. (2014). Targeting FGFR1-amplified lung squamous cell carcinoma with the selective pan-FGFR inhibitor BGJ398.. Journal of Clinical Oncology. 32(15_suppl). 8034–8034. 35 indexed citations

6.

Krbek, Thomas, et al.. (2013). Locoregional recurrence after pulmonary segmentectomy of non-small cell lung cancer. European Respiratory Journal. 42(Suppl 57). P458–P458. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact